12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Company News  |  Deals

Lexicon, Nuevolution, Duke University, Howard Hughes Medical Institute deal

The parties partnered to investigate the biological mechanism of action of an undisclosed GPCR drug target. Nuevolution will provide its Chemetics fragment-based screening...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >